Clorotepine

This classification denotes a dopamine antagonist with the molecular formula C19H21ClN2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E65W20MU7A, chemically known as 1-(8-chloro-10,11-dihydrodibenzo(b,f)thiepin-10-yl)-4-methylpiperazine but generally known as clorotepine, which bears US NIH Compound Identifier 1238. European Medicines Agency schedules Clorotepine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06765MIG. The term CLOROTEPINE is an International Non-Proprietary Name. CLOROTEPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clorotepine under HS 29349990 and SITC 51579. As of Q4 2014, CLOROTEPINE remains the US FDA Preferred Term for this commodity. Clorotepine bears US NLM identifiers UMLS ID C0069353 and NCI Concept Code C77572. SMILES: CLC1CC2C(N3CCN(CC3)C)CC3C(SC2CC1)CCCC3.